← SynDRA
ETHOTOIN
SynDRA canonical compound SYN0003680 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · OTC |
|---|
| Primary target(s) | SCN5A |
|---|
| Mechanism of action | Hydantoin antiepileptic |
|---|
| Indication | seizures |
|---|
| Disease area | neurology/psychiatry |
|---|
All known targets
- SCN5A
- SCN10A
- SCN11A
- SCN1A
- SCN2A
- SCN3A
- SCN4A
- SCN7A
- SCN8A
- SCN9A
Mechanisms of action (all sources)
- Hydantoin antiepileptic
- SCN1A BLOCKER
- Sodium channel alpha subunit blocker
- SCN5A BLOCKER
- SCN4A BLOCKER
- SCN7A BLOCKER
- SCN2A BLOCKER
- SCN9A BLOCKER
- SCN3A BLOCKER
- SCN11A BLOCKER
- SCN8A BLOCKER
- SCN10A BLOCKER
Drug classes
- Anticonvulsants
- Cardiovascular Agents
- Central Nervous System Agents
- Membrane Transport Modulators
- Sodium Channel Blockers
- Voltage-Gated Sodium Channel Blockers
- Anti-epileptic Agent
ATC classes
Cross-references
Synonyms
- accenon
- peganone
- Ethotoine
- Etotoina
- Accenon
- NSC-760074
- Peganone
- Ethotoinum
- Pegoanone
- Abbott brand of ethotoin
- Accenon (TN)
- Ethotoine [INN-French]
- Ethotoinum [INN-Latin]
- Etotoina [INN-Spanish]
- Peganone (TN)
- Ethotoin [INN:BAN:JAN]
- Ethotoin (JAN/USP/INN)
- (+-)-3-Ethyl-5-phenylhydantoin
- 1-Ethyl-2,5-dioxo-4-phenylimidazolidine
- 3-Ethyl-5-phenyl-2,4-imidazolidinedione
- 3-Ethyl-5-phenylhydantoin
- 3-Ethyl-5-phenylimidazolidin-2,4-dione
- 3-ethyl-5-phenylimidazolidine-2,4-dione
- Hydantoin, 3-ethyl-5-phenyl-
- 2,4-Imidazolidinedione, 3-ethyl-5-phenyl-
- NSC 760074
- 3-ethyl-5-phenyl-imidazolidine-2,4-dione
- CHEBI:4888
- DTXCID903020
- 1-ethyl-2-hydroxy-4-phenyl-4,5-dihydro-1H-imidazol-5-one
- RefChem:56515
- N03AB01
- AC-695; Accenon
- (+/-)-3-ethyl-5-phenylhydantoin
- HSDB 3580
- EINECS 201-665-1
- MFCD00072127
- BRN 0188272
Look up ETHOTOIN in the interactive SynDRA portal →